2024
DOI: 10.1016/j.bioorg.2023.107095
|View full text |Cite
|
Sign up to set email alerts
|

Targeting JAK2/STAT3 for the treatment of cancer: A review on recent advancements in molecular development using structural analysis and SAR investigations

Rupali Kohal,
Priya Bisht,
Ghanshyam Das Gupta
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 119 publications
0
0
0
Order By: Relevance
“…Recently, the JAK2/ STAT3 pathway has attracted attention as a potential target for creating new anti-tumor drugs. It shows promise in treating various types of solid cancers [8]. Many studies have demonstrated that numerous bioactive compounds from natural plants or Chinese medicine have shown antitumor properties against multiple cancers by inhibiting the JAK2/STAT3 pathway in vivo and in intro [9][10][11].…”
Section: Introductionmentioning
confidence: 99%
“…Recently, the JAK2/ STAT3 pathway has attracted attention as a potential target for creating new anti-tumor drugs. It shows promise in treating various types of solid cancers [8]. Many studies have demonstrated that numerous bioactive compounds from natural plants or Chinese medicine have shown antitumor properties against multiple cancers by inhibiting the JAK2/STAT3 pathway in vivo and in intro [9][10][11].…”
Section: Introductionmentioning
confidence: 99%